Showing results (71-80 of 144) with videos related to
Sort By:
Pageof 15
Pediatric Blood & Cancer|September 1, 2020
Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in IndiaShyam Srinivasan, Nirmalya Roy Moulik, Anand Kc, et al.Leukemia & Lymphoma|December 21, 2013
Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?Siddhartha Laskar, Deepak P Kumar, Nehal Khanna, et al.Journal of Global Oncology|July 2, 2019
Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric OncologistsGabriel Revon-Rivière, Shripad Banavali, Laila Heississen, et al.Journal of Adolescent and Young Adult Oncology|July 25, 2020
High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy RegimenKalasekhar Vijayasekharan, Subramaniam Ramanathan, Girish Chinnaswamy, et al.Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in IndiaShyam Srinivasan, Mili Aggarwal, Nikhil Patkar, et al.Journal of Global Oncology|August 24, 2017
Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical GuidelineVijay Patil, Vanita Noronha, Amit Joshi, et al.Pediatric Blood & Cancer|July 25, 2020
Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing worldBadira Cheriyalinkal Parambil, Tushar Vora, Hari Sankaran, et al.Pediatric Blood & Cancer|March 7, 2025
Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single-Center StudyAmrutha Narayana Murthy, Shyam Srinivasan, Vasundhara Patil, et al.Cytometry. Part B, Clinical Cytometry|September 1, 2020
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristicsDevasis Panda, Gaurav Chatterjee, Rohan Sardana, et al.JCO Clinical Cancer Informatics|January 21, 2026
PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic LeukemiaSubikksha Saravanan, Raghunathan Rengaswamy, Gaurav Narula, et al.Pageof 15